bpc 157 and thymosin beta 4 benefits – A Healing Peptide | Regenerative Medicine Center Regeneration or Risk? A Narrative

Their products are top of the line

When the FDA places a peptide in a restricted or high-risk category [known as Category 2], it is explicitly signaling that it has identified safety concerns and that enforcement discretion does not apply. But, as Hajduczok notes, just because something is not FDA-approved doesnt mean its illegal to compound, but the restricted peptides should not be compounded

Researchers proposed that the mechanisms underlying these regenerative interactions may involve the modulation of cellular differentiation processes and the synthesis of proteins important for tissue repair in laboratory settings

is a high-tech enterprise specializing in the research and development, production and sales of veterinary drugs